WASHINGTON (AP) — The Food and Drug Administration on Tuesday approved a new heart pump for patients with severe heart failure who are awaiting a heart transplant.
Regulators approved HeartWare's Ventricular Assist System, a battery-powered device that is implanted in the chest, where it helps the heart's lower left chamber pump blood throughout the body.
The FDA has previously approved similar devices, known as ventricular assist devices, but HeartWare's device is smaller and may be easier to implant in some patients.
FDA says the approval was based on a company study of 137 advanced heart failure patients implanted with the device. Study results showed rates of adverse events, including infection and stroke, were similar to those seen with older devices.
Medical device maker HeartWare International Inc. is based in Framingham, Mass.
Concealed Carrier Rehired After Saving GM Worker From Stabbing
Hey, The Supreme Court Might Decide On ‘Assault Weapons’ After All
TSA: Total Security Abyss | Human Events
Benghazi for Dummies - News Headlines: U.S, National, World, Conservative, Political, Politics, Election, Latest, Breaking
YUGE ultimatum: Trump tells Cruz to do three things — or he'll sue over eligibility
Donald Trump Was Right. Democrats Have Filed A Birther Lawsuit Against Ted Cruz | RedState
Reid to Grayson: Get out; Grayson to Reid: Great job in 2014, failing figurehead